Mr. Harris has more than 20 years of experience as a biopharmaceutical executive and commercial leader. He currently serves as Chief Commercial Officer at Ultragenyx where he is responsible for all worldwide commercial operations. Prior to his role there, Mr. Harris spent six years at Crescendo Bioscience, a subsidiary of Myriad Genetics, Inc., where he held various leadership positions, most recently as Vice President of Commercial, leading all aspects of marketing, sales, managed care and customer service. He has been involved in several notable launches, including Crysvita®, Mepsevii®, Dojolvi®, Tarceva®, Tysabri® and Vectra-DA®. Mr. Harris currently serves on the Board of Directors of Denali Therapeutics and Inozyme Pharma. He received his Masters of Business Administration at the Wharton School of Business, and Bachelor of Science at the United States Naval Academy where he began his professional career serving as a Lieutenant Commander in Naval Aviation and Congressional Fellow for the United States Navy.